Anebulo Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small …

Biotechnology
US, Lakeway [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ANEB's Analysis
CIK: 1815974 CUSIP: 034569103 ISIN: US0345691036 LEI: - UEI: -
Secondary Listings
ANEB has no secondary listings inside our databases.